The next generation of Evidence - based viscosupplementation
1 injection provides pain relief within a week and lasts for at least 6 months...*
*When compared to placebo
What is
osteoarthritis?
Discover the Sinovial Line of products...
1 intra-articular injection which will provide pain relief for at least 6 months.
Sinovial HL 64
- For larger joints (Hip,Knee, Shoulder)
- Hybrid HA injection [high and low molecular weight]
- Single-injection
- Provides Lubrication, nourishment and shock absorption
- Pain relief within 7 days and lasting minimum 6 months
- Established safety & tolerability
- Mild-moderate OA
Sinovial HL 32
- For smaller joints (Wrist, Hand, Ankles, Feet)
- Hybrid HA injection [high and low molecular weight]
- Single-injection
- Provides Lubrication, nourishment and shock absorption
- Pain relief within 7 days and lasting minimum 6 months
- Established safety & tolerability
- Mild-moderate OA
Sinogel
- For Hips and Knees
- Chondroitin and High molecular weight hyaluronic acid (HA) injection
- Single-injection
- Provides Lubrication, nourishment and shock absorption
- Pain relief within 7 days and lasting minimum 6 months
- Established safety & tolerability
- Moderate-severe OA
- For highly active people
Step-by-Step accessing Sinovial therapy:
Find your closest clinic here...
What people are saying about the Sinovial Line
IBSA – Who are we?
We are a Swiss multinational pharmaceutical company, founded in 1945 in Lugano. We are present in over 90 countries on 5 continents with 20 subsidiaries in Europe, China and the United States. IBSA UK became an affiliate in January 2023.
IBSA is engaged in 10 therapeutic areas, one of which is Osteoarticular, where our Sinovial line falls under. IBSA are committed to improving adherence to treatment with solutions that are increasingly closer to people, through continuous research of innovative formulations and delivery systems. We are one of the world’s leaders in HA-based products.
